Alto Neuroscience Underwriting Agreement
Alto Neuroscience Inc. confirmed an agreement with BofA Securities to sell 3.77 million common shares. This filing outlines the terms for the registered direct offering of new equity.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed